{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T07:14:14Z","timestamp":1768029254618,"version":"3.49.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,9]]},"DOI":"10.7759\/cureus.101195","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T03:52:52Z","timestamp":1768017172000},"source":"Crossref","is-referenced-by-count":0,"title":["The Role of 68Ga-Pentixafor and 18F-Fluorodeoxyglucose (18F-FDG) PET\/CT in a Case of Multiple Myeloma"],"prefix":"10.7759","author":[{"given":"Abhishek","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamojit","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manisha","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Purshottam","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binay","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.16.17219","article-title":"A comparison of different staging systems for multiple myeloma: can the MRI pattern play a prognostic role?","volume":"209","author":"Filonzi G","year":"2017","unstructured":"Filonzi G, Mancuso K, Zamagni E, et al.. A comparison of different staging systems for multiple myeloma: can the MRI pattern play a prognostic role?. AJR Am J Roentgenol. 2017, 209:152-8. 10.2214\/AJR.16.17219","journal-title":"AJR Am J Roentgenol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fnume.2021.808627","article-title":"(18) F-FDG PET\/CT and MRI in the management of multiple myeloma: a comparative review","volume":"1","author":"Mesguich C","year":"2021","unstructured":"Mesguich C, Hulin C, Latrabe V, Lascaux A, Bordenave L, Hindi\u00e9 E. (18) F-FDG PET\/CT and MRI in the management of multiple myeloma: a comparative review. Front Nucl Med. 2021, 1:808627. 10.3389\/fnume.2021.808627","journal-title":"Front Nucl Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7150\/thno.5760","article-title":"CXCR4 chemokine receptor overview: biology, pathology and applications in imaging and therapy","volume":"3","author":"Jacobson O","year":"2013","unstructured":"Jacobson O, Weiss ID. CXCR4 chemokine receptor overview: biology, pathology and applications in imaging and therapy. Theranostics. 2013, 3:1-2. 10.7150\/thno.5760","journal-title":"Theranostics"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262206","article-title":"(68)Ga-pentixafor PET\/CT for detection of chemokine receptor cxcr4 expression in myeloproliferative neoplasms","volume":"63","author":"Kraus S","year":"2022","unstructured":"Kraus S, Dierks A, Rasche L, et al.. (68)Ga-pentixafor PET\/CT for detection of chemokine receptor cxcr4 expression in myeloproliferative neoplasms. J Nucl Med. 2022, 63:96-9. 10.2967\/jnumed.121.262206","journal-title":"J Nucl Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s41181-023-00187-2","article-title":"Automated synthesis and quality control of [(68)Ga]Ga-PentixaFor using the Gaia\/Luna Elysia-Raytest module for CXCR4 PET imaging","volume":"8","author":"Daniel T","year":"2023","unstructured":"Daniel T, Balouzet Ravinet C, Clerc J, Batista R, Mouraeff Y. Automated synthesis and quality control of [(68)Ga]Ga-PentixaFor using the Gaia\/Luna Elysia-Raytest module for CXCR4 PET imaging. EJNMMI Radiopharm Chem. 2023, 8:4. 10.1186\/s41181-023-00187-2","journal-title":"EJNMMI Radiopharm Chem"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2023.09.002","article-title":"Advances in PET imaging of the CXCR4 receptor: [(68)Ga]Ga-PentixaFor","volume":"54","author":"Lindenberg L","year":"2024","unstructured":"Lindenberg L, Ahlman M, Lin F, Mena E, Choyke P. Advances in PET imaging of the CXCR4 receptor: [(68)Ga]Ga-PentixaFor. Semin Nucl Med. 2024, 54:163-70. 10.1053\/j.semnuclmed.2023.09.002","journal-title":"Semin Nucl Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.50183","article-title":"Gallium68-labeled fibroblast activation protein inhibitor (68Ga-FAPI) PET\/CT as an alternative to fluoro18-fluorodeoxyglucose (18F-FDG) PET\/CT: discussion in a case of metastatic adenocarcinoma of pancreas","volume":"15","author":"Kumar A","year":"2023","unstructured":"Kumar A, Kumar B, Kumar Upadhyay A, Muthu GS, Mitra S. Gallium68-labeled fibroblast activation protein inhibitor (68Ga-FAPI) PET\/CT as an alternative to fluoro18-fluorodeoxyglucose (18F-FDG) PET\/CT: discussion in a case of metastatic adenocarcinoma of pancreas. Cureus. 2023, 15:e50183. 10.7759\/cureus.50183","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-009-0829-0","article-title":"Role of radiography, MRI and FDG-PET\/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma","volume":"88","author":"L\u00fctje S","year":"2009","unstructured":"L\u00fctje S, de Rooy JW, Croockewit S, Koedam E, Oyen WJ, Raymakers RA. Role of radiography, MRI and FDG-PET\/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma. Ann Hematol. 2009, 88:1161-8. 10.1007\/s00277-009-0829-0","journal-title":"Ann Hematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-213280","article-title":"F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma","volume":"114","author":"Bartel TB","year":"2009","unstructured":"Bartel TB, Haessler J, Brown TL, et al.. F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma. Blood. 2009, 114:2068-76. 10.1182\/blood-2009-03-213280","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2006.7.1.57","article-title":"False positive and false negative FDG-PET scans in various thoracic diseases","volume":"7","author":"Chang JM","year":"2006","unstructured":"Chang JM, Lee HJ, Goo JM, Lee HY, Lee JJ, Chung JK, Im JG. False positive and false negative FDG-PET scans in various thoracic diseases. Korean J Radiol. 2006, 7:57-69. 10.3348\/kjr.2006.7.1.57","journal-title":"Korean J Radiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3217","article-title":"CXCR4 over-expression and survival in cancer: a system review and meta-analysis","volume":"6","author":"Zhao H","year":"2015","unstructured":"Zhao H, Guo L, Zhao H, Zhao J, Weng H, Zhao B. CXCR4 over-expression and survival in cancer: a system review and meta-analysis. Oncotarget. 2015, 6:5022-40. 10.18632\/oncotarget.3217","journal-title":"Oncotarget"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.261964","article-title":"Functional characterization of adrenocortical masses in nononcologic patients using (68)Ga-pentixafor","volume":"63","author":"Ding J","year":"2022","unstructured":"Ding J, Tong A, Zhang Y, et al.. Functional characterization of adrenocortical masses in nononcologic patients using (68)Ga-pentixafor. J Nucl Med. 2022, 63:368-75. 10.2967\/jnumed.121.261964","journal-title":"J Nucl Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7150\/thno.16576","article-title":"[(68)Ga]Pentixafor-PET\/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - comparison to [(18)F]FDG and laboratory values","volume":"7","author":"Lapa C","year":"2017","unstructured":"Lapa C, Schreder M, Schirbel A, et al.. [(68)Ga]Pentixafor-PET\/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - comparison to [(18)F]FDG and laboratory values. Theranostics. 2017, 7:205-12. 10.7150\/thno.16576","journal-title":"Theranostics"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20211272","article-title":"Imaging CXCR4 receptors expression for staging multiple myeloma by using (68)Ga-Pentixafor PET\/CT: comparison with (18)F-FDG PET\/CT","volume":"95","author":"Shekhawat AS","year":"2022","unstructured":"Shekhawat AS, Singh B, Malhotra P, et al.. Imaging CXCR4 receptors expression for staging multiple myeloma by using (68)Ga-Pentixafor PET\/CT: comparison with (18)F-FDG PET\/CT. Br J Radiol. 2022, 95:20211272. 10.1259\/bjr.20211272","journal-title":"Br J Radiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/452229-the-role-of-68ga-pentixafor-and-18f-fluorodeoxyglucose-18f-fdg-petct-in-a-case-of-multiple-myeloma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T03:52:54Z","timestamp":1768017174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/452229-the-role-of-68ga-pentixafor-and-18f-fluorodeoxyglucose-18f-fdg-petct-in-a-case-of-multiple-myeloma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.101195","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,9]]}}}